Form D · Biotechnology
CannTrust Holdings Inc.
Vaughan, A6 · CIK 0001652499
Offering snapshot reported Nov 2, 2018 · SEC filing
- Reported sold
- $7.1M Offering amount: $28.1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 17, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 2, 2018 | Initial | $7,104,513 | No comparison | 1 | SEC filing |
| Mar 8, 2017 | Initial | $1,020,000 | No comparison | 15 | SEC filing |
| Dec 23, 2016 | Initial | $0 | No comparison | 0 | SEC filing |
| Sep 4, 2015 | Initial | $1,085,627 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-324944
The additional $20,954,170 may be received upon the exercise of warrants sold inside the U.S. U.S. dollar amounts are based on the Bank of Canada average rate of exchange reported on October 17, 2018, which was CDN$1.2994=US$1.00.
Both common shares and warrants were issued. The warrants can be exercised until for an additional common share at a price per share equal to the 5-day volume-weighted average price on the Toronto Stock Exchange until October 17, 2023.
Source: Form D, filed Nov 2, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stanley Abramowitz | Executive |
| Ian Abramowitz | Executive |
| Aubrey Dan | Director, Executive |
| Mark Dawber | Director |
| Mark Litwin | Director |
| Robert Marcovitch | Director |
| Shawna Page | Director |
| Eric Paul | Director, Executive |
| Norman Paul | Director |
| Brad Rogers | Executive |
| Mitchell Sanders | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3280 Langstaff Road Unit 1
Vaughan, A6, L4K4Z8
Vaughan, A6, L4K4Z8